Armagh firm Almac expands with new Singapore operation
Co Armagh pharmaceutical firm Almac Group has opened new Asia Pacific regional headquarters in Singapore.
The Craigavon-based firm revealed the new operational facilities include primary and secondary packaging for clinical trials as well as distribution and interactive response technology services. Almac said the facility will allow it to better serve its pharmaceutical clients, either conducting regional trials or expanding to international markets as well as global clients who are carrying out clinical trials in the region.
The president and managing director of Almac's clinical services business unit, Dr Robert Dunlop, said: "Asia Pacific is a vital region for us, as currently 23% of global clinical trials for new pharmaceutical products are being conducted here.
"By basing our regional headquarters and operations in Singapore, we are better equipped to support our Asia-based clients in their own time zone and languages." Kevin Lai, of Biomedical Sciences and Consumer Businesses, Singapore Economic Development Board (EDB), said it "welcomed Almac's investment into the vibrant ecosystem of biomedical sciences companies in Singapore". Almac employs more than 3,700 people, including 2,300 in Craigavon.